- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3327EUR$3,500USD£2,795GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Gonorrhea Test market is a segment of the Infectious Disease Testing market. It is used to detect the presence of the bacteria Neisseria gonorrhoeae, which is the cause of the sexually transmitted infection gonorrhea. Tests for gonorrhea are typically conducted using a urine sample or a swab of the infected area. The results of the test are used to diagnose the infection and to determine the best course of treatment.
Gonorrhea testing is widely available in both clinical and non-clinical settings. In clinical settings, tests are typically conducted by a healthcare provider and results are available within a few days. Non-clinical settings, such as pharmacies and home testing kits, offer rapid results and are becoming increasingly popular.
Companies in the Gonorrhea Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Quidel, Roche Diagnostics, and Siemens Healthineers. Show Less Read more